M-Ras/R-Ras3, a Transforming Ras Protein Regulated by Sos1, GRF1, and p120 Ras GTPase-activating Protein, Interacts with the Putative Ras Effector AF6
Open accessAbstract
M-Ras is a Ras-related protein that shares approximately 55% identity with K-Ras and TC21. The M-Ras message was widely expressed but was most predominant in ovary and brain. Similarly to Ha-Ras, expression of mutationally activated M-Ras in NIH 3T3 mouse fibroblasts or C2 myoblasts resulted in cellular transformation or inhibition of differentiation, respectively. M-Ras only weakly activated extracellular signal-regulated kinase 2 (ERK2), but it cooperated with Raf, Rac, and Rho to induce transforming foci in NIH 3T3 cells, suggesting that M-Ras signaled via alternate pathways to these effectors. Although the mitogen-activated protein kinase/ERK kinase inhibitor, PD98059, blocked M-Ras-induced transformation, M-Ras was more effective than an activated mitogen-activated protein kinase/ERK kinase mutant at inducing focus formation. These data indicate that multiple pathways must contribute to M-Ras-induced transformation. M-Ras interacted poorly in a yeast two-hybrid assay with multiple Ras effectors, including c-Raf-1, A-Raf, B-Raf, phosphoinositol-3 kinase delta, RalGDS, and Rin1. Although M-Ras coimmunoprecipitated with AF6, a putative regulator of cell junction formation, overexpression of AF6 did not contribute to fibroblast transformation, suggesting the possibility of novel effector proteins. The M-Ras GTP/GDP cycle was sensitive to the Ras GEFs, Sos1, and GRF1 and to p120 Ras GAP. Together, these findings suggest that while M-Ras is regulated by similar upstream stimuli to Ha-Ras, novel targets may be responsible for its effects on cellular transformation and differentiation.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
MRAS shares approximately 50% sequence identity with other RAS isoforms and can interact with some common RAS effectors and regulators, such as RAF, PI3K, RalGDS and SOS.
“While MRAS shares approximately 50% sequence identity with other RAS isoforms and can interact with some of the common RAS effectors and regulators, such as RAF, PI3K, RalGDS and SOS38,50,51”
From Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance (2024) · cites this paper as [38]
MRAS, alone, is a poor activator of MAPK signaling.
“This is consistent with previous findings that MRAS, alone, is a poor activator of MAPK signaling38,48,49.”
From Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance (2024) · cites this paper as [38]
MRAS may regulate other signaling pathways involving Rho, Ral or Rap GTPases, contributing to tumor cell migration adhesion, endocytosis or invasion.
“This suggests that MRAS may regulate other signaling pathways involving Rho, Ral or Rap GTPases38,53,54, contributing to tumor cell migration adhesion, endocytosis or invasion.”
From Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance (2024) · cites this paper as [38]
SOS1 and RasGRP1 facilitate GTP-loading of MRAS, which together with SHOC2 and PP1C forms a phosphatase complex that contributes to increased activation of RAS-MAPK signaling through dephosphorylation of inhibitory sites on RAF kinases.
“SOS1 and RasGRP1 have been shown to facilitate the GTP-loading of MRAS37,38, which, together with SHOC2 and PP1C, forms a phosphatase complex that contributes to the increased activation of RAS-MAPK signaling through dephosphorylation of inhibitory sites on RAF kinases40.”
From Co-targeting SOS1 enhances the antitumor effects of KRASG12C inhibitors by addressing intrinsic and acquired resistance (2024) · cites this paper as [38]
The citation lists haven’t been fetched yet
References 73 · Cited by 119
- Authors
- Quilliam, L. A., Castro, A. F., Rogers-Graham, K. S., Martin, C. B., Der, C. J., & Bi, C.
- Affiliations
- Indiana University Indianapolis (US)
- University of North Carolina at Chapel Hill (US)
- Corresponding author
- Quilliam, Lawrence A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1999-08
- Volume
- 274
- Issue
- 34
- Pages
- 23850-23857
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2009635345
- Cited by
- 119
- References
- 73
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 3 · 2021: 7 · 2020: 7 · 2019: 2 · 2018: 1 · 2017: 1 · 2016: 4 · 2015: 3 · 2014: 1 · 2013: 3 · 2012: 3
- FWCI
- 3.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- National Institutes of Health (7r29ca063139-03, CA69577)
- National Cancer Institute (R01CA069577, CA 69577, CA-63139)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- M-Ras, cell transformation, cell differentiation, Ras effectors, SOS1, ERK2, Raf, RalGDS, cell junctions, PD98059, MAPK signaling
- MeSH terms
- Animals, Cell Differentiation, Cell Transformation, Neoplastic, Enzyme Activation, Flavonoids, Fungal Proteins, Myosins, Proteins, Repressor Proteins, 3T3 Cells, Kinesins, Protein Serine-Threonine Kinases, Calcium-Calmodulin-Dependent Protein Kinases, ras Proteins, Cell Cycle Proteins, Mitogen-Activated Protein Kinase 1, GTP Phosphohydrolases, Monomeric GTP-Binding Proteins, ras-GRF1, GTPase-Activating Proteins, ras GTPase-Activating Proteins, SOS1 Protein, MAP Kinase Kinase Kinase 1, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review